Medlive Technology : (1) RENEWAL OF CONTINUING CONNECTED TRANSACTIONS AND (2) INCREASE OF MONETARY CAP FOR CONTINUING CONNECTED TRANSACTIONS
March 24, 2022 at 12:13 pm
Share
[title]
[date]
[link]
[market]
[doc type]
[stock code]
[stock name]
(1) RENEWAL OF CONTINUING CONNECTED TRANSACTIONS AND (2) INCREASE OF MONETARY CAP FOR CONTINUING CONNECTED TRANSACTIONS
24/03/2022 20:01
Link
SEHK
pdf
02192
MEDLIVE
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/03/2022 20:00
Link
SEHK
htm
01898
CHINA COAL
OVERSEAS REGULATORY ANNOUNCEMENT
24/03/2022 19:58
Link
SEHK
pdf
01179
HUAZHU-S
SPECIAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021
24/03/2022 19:58
Link
SEHK
pdf
02883
CHINA OILFIELD
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/03/2022 19:58
Link
SEHK
htm
01839
CIMC VEHICLES
ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
24/03/2022 19:57
Link
SEHK
pdf
00934
SINOPEC KANTONS
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/03/2022 19:56
Link
SEHK
htm
01898
CHINA COAL
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/03/2022 19:56
Link
SEHK
htm
00576
ZHEJIANGEXPRESS
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021
24/03/2022 19:54
Link
SEHK
pdf
02883
CHINA OILFIELD
MONTHLY UPDATE ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
24/03/2022 19:54
Link
SEHK
pdf
02011
CHINA APEX GP
Cash Dividend Announcement for Equity Issuer
24/03/2022 19:52
Link
SEHK
pdf
02192
MEDLIVE
AUDIT COMMITTEE UNDER THE BOARD OF DIRECTORS TERMS OF REFERENCE
24/03/2022 19:51
Link
SEHK
pdf
01839
CIMC VEHICLES
Final Dividend for the Year Ended 31 December 2021
24/03/2022 19:51
Link
SEHK
pdf
02628
CHINA LIFE
INSIDE INFORMATION / POSITIVE PROFIT ALERT
24/03/2022 19:50
Link
SEHK
pdf
00226
LIPPO
DISCLOSEABLE TRANSACTION - DISPOSAL OF THE DEBENTURE AND MEMBERSHIP
24/03/2022 19:49
Link
SEHK
pdf
00413
SC HOLDINGS
Notification Letter to Non-registered Holder and Request Form
24/03/2022 19:48
Link
SEHK
pdf
01913
PRADA
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
24/03/2022 19:48
Link
SEHK
pdf
01898
CHINA COAL
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section.
24/03/2022 19:48
Link
SEHK
docx
02883
CHINA OILFIELD
Cash Dividend Announcement for Equity Issuer
24/03/2022 19:47
Link
SEHK
pdf
06083
WORLD-LINK LOG
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/03/2022 19:47
Link
SEHK
htm
02628
CHINA LIFE
Attachments
Original Link
Original Document
Permalink
Disclaimer
Medlive Technology Co. Ltd. published this content on 24 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 March 2022 12:11:12 UTC.
Medlive Technology Co Ltd is a China-based investment holding company mainly operates online professional physician platform. The Company mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The Company mainly conducts its business within domestic market.